Global Rufinamide Market Size, Status and Forecast 2024-2031

Report ID: 917513 | Published Date: Mar 2026 | No. of Page: 87 | Base Year: 2025 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Rufinamide Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Tablets
        1.2.3 Oral suspension
    1.3 Market by Application
        1.3.1 Global Rufinamide Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Adults
        1.3.3 Pediatric patients
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Rufinamide Market Perspective (2016-2027)
    2.2 Rufinamide Growth Trends by Regions
        2.2.1 Rufinamide Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Rufinamide Historic Market Share by Regions (2016-2021)
        2.2.3 Rufinamide Forecasted Market Size by Regions (2022-2027)
    2.3 Rufinamide Industry Dynamic
        2.3.1 Rufinamide Market Trends
        2.3.2 Rufinamide Market Drivers
        2.3.3 Rufinamide Market Challenges
        2.3.4 Rufinamide Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Rufinamide Players by Revenue
        3.1.1 Global Top Rufinamide Players by Revenue (2016-2021)
        3.1.2 Global Rufinamide Revenue Market Share by Players (2016-2021)
    3.2 Global Rufinamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Rufinamide Revenue
    3.4 Global Rufinamide Market Concentration Ratio
        3.4.1 Global Rufinamide Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Rufinamide Revenue in 2020
    3.5 Rufinamide Key Players Head office and Area Served
    3.6 Key Players Rufinamide Product Solution and Service
    3.7 Date of Enter into Rufinamide Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Rufinamide Breakdown Data by Type
    4.1 Global Rufinamide Historic Market Size by Type (2016-2021)
    4.2 Global Rufinamide Forecasted Market Size by Type (2022-2027)

5 Rufinamide Breakdown Data by Application
    5.1 Global Rufinamide Historic Market Size by Application (2016-2021)
    5.2 Global Rufinamide Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Rufinamide Market Size (2016-2027)
    6.2 North America Rufinamide Market Size by Type
        6.2.1 North America Rufinamide Market Size by Type (2016-2021)
        6.2.2 North America Rufinamide Market Size by Type (2022-2027)
        6.2.3 North America Rufinamide Market Size by Type (2016-2027)
    6.3 North America Rufinamide Market Size by Application
        6.3.1 North America Rufinamide Market Size by Application (2016-2021)
        6.3.2 North America Rufinamide Market Size by Application (2022-2027)
        6.3.3 North America Rufinamide Market Size by Application (2016-2027)
    6.4 North America Rufinamide Market Size by Country
        6.4.1 North America Rufinamide Market Size by Country (2016-2021)
        6.4.2 North America Rufinamide Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Rufinamide Market Size (2016-2027)
    7.2 Europe Rufinamide Market Size by Type
        7.2.1 Europe Rufinamide Market Size by Type (2016-2021)
        7.2.2 Europe Rufinamide Market Size by Type (2022-2027)
        7.2.3 Europe Rufinamide Market Size by Type (2016-2027)
    7.3 Europe Rufinamide Market Size by Application
        7.3.1 Europe Rufinamide Market Size by Application (2016-2021)
        7.3.2 Europe Rufinamide Market Size by Application (2022-2027)
        7.3.3 Europe Rufinamide Market Size by Application (2016-2027)
    7.4 Europe Rufinamide Market Size by Country
        7.4.1 Europe Rufinamide Market Size by Country (2016-2021)
        7.4.2 Europe Rufinamide Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Rufinamide Market Size (2016-2027)
    8.2 Asia-Pacific Rufinamide Market Size by Type
        8.2.1 Asia-Pacific Rufinamide Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Rufinamide Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Rufinamide Market Size by Type (2016-2027)
    8.3 Asia-Pacific Rufinamide Market Size by Application
        8.3.1 Asia-Pacific Rufinamide Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Rufinamide Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Rufinamide Market Size by Application (2016-2027)
    8.4 Asia-Pacific Rufinamide Market Size by Region
        8.4.1 Asia-Pacific Rufinamide Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Rufinamide Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Rufinamide Market Size (2016-2027)
    9.2 Latin America Rufinamide Market Size by Type
        9.2.1 Latin America Rufinamide Market Size by Type (2016-2021)
        9.2.2 Latin America Rufinamide Market Size by Type (2022-2027)
        9.2.3 Latin America Rufinamide Market Size by Type (2016-2027)
    9.3 Latin America Rufinamide Market Size by Application
        9.3.1 Latin America Rufinamide Market Size by Application (2016-2021)
        9.3.2 Latin America Rufinamide Market Size by Application (2022-2027)
        9.3.3 Latin America Rufinamide Market Size by Application (2016-2027)
    9.4 Latin America Rufinamide Market Size by Country
        9.4.1 Latin America Rufinamide Market Size by Country (2016-2021)
        9.4.2 Latin America Rufinamide Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Rufinamide Market Size (2016-2027)
    10.2 Middle East & Africa Rufinamide Market Size by Type
        10.2.1 Middle East & Africa Rufinamide Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Rufinamide Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Rufinamide Market Size by Type (2016-2027)
    10.3 Middle East & Africa Rufinamide Market Size by Application
        10.3.1 Middle East & Africa Rufinamide Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Rufinamide Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Rufinamide Market Size by Application (2016-2027)
    10.4 Middle East & Africa Rufinamide Market Size by Country
        10.4.1 Middle East & Africa Rufinamide Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Rufinamide Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Eisai
        11.1.1 Eisai Company Details
        11.1.2 Eisai Business Overview
        11.1.3 Eisai Rufinamide Introduction
        11.1.4 Eisai Revenue in Rufinamide Business (2016-2021)
        11.1.5 Eisai Recent Development
    11.2 Glenmark Pharms
        11.2.1 Glenmark Pharms Company Details
        11.2.2 Glenmark Pharms Business Overview
        11.2.3 Glenmark Pharms Rufinamide Introduction
        11.2.4 Glenmark Pharms Revenue in Rufinamide Business (2016-2021)
        11.2.5 Glenmark Pharms Recent Development
    11.3 Mylan
        11.3.1 Mylan Company Details
        11.3.2 Mylan Business Overview
        11.3.3 Mylan Rufinamide Introduction
        11.3.4 Mylan Revenue in Rufinamide Business (2016-2021)
        11.3.5 Mylan Recent Development
    11.4 West-ward Pharms
        11.4.1 West-ward Pharms Company Details
        11.4.2 West-ward Pharms Business Overview
        11.4.3 West-ward Pharms Rufinamide Introduction
        11.4.4 West-ward Pharms Revenue in Rufinamide Business (2016-2021)
        11.4.5 West-ward Pharms Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Rufinamide Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Tablets
    Table 3. Key Players of Oral suspension
    Table 4. Global Rufinamide Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Rufinamide Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Rufinamide Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Rufinamide Market Share by Regions (2016-2021)
    Table 8. Global Rufinamide Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Rufinamide Market Share by Regions (2022-2027)
    Table 10. Rufinamide Market Trends
    Table 11. Rufinamide Market Drivers
    Table 12. Rufinamide Market Challenges
    Table 13. Rufinamide Market Restraints
    Table 14. Global Rufinamide Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Rufinamide Market Share by Players (2016-2021)
    Table 16. Global Top Rufinamide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rufinamide as of 2020)
    Table 17. Ranking of Global Top Rufinamide Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Rufinamide Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Rufinamide Product Solution and Service
    Table 21. Date of Enter into Rufinamide Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Rufinamide Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Rufinamide Revenue Market Share by Type (2016-2021)
    Table 25. Global Rufinamide Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Rufinamide Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Rufinamide Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Rufinamide Revenue Market Share by Application (2016-2021)
    Table 29. Global Rufinamide Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Rufinamide Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Rufinamide Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Rufinamide Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Rufinamide Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Rufinamide Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Rufinamide Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Rufinamide Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Rufinamide Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Rufinamide Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Rufinamide Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Rufinamide Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Rufinamide Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Rufinamide Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Rufinamide Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Rufinamide Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Rufinamide Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Rufinamide Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Rufinamide Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Rufinamide Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Rufinamide Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Rufinamide Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Rufinamide Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Rufinamide Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Rufinamide Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Rufinamide Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Rufinamide Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Rufinamide Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Rufinamide Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Rufinamide Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Rufinamide Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Rufinamide Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Eisai Company Details
    Table 62. Eisai Business Overview
    Table 63. Eisai Rufinamide Product
    Table 64. Eisai Revenue in Rufinamide Business (2016-2021) & (US$ Million)
    Table 65. Eisai Recent Development
    Table 66. Glenmark Pharms Company Details
    Table 67. Glenmark Pharms Business Overview
    Table 68. Glenmark Pharms Rufinamide Product
    Table 69. Glenmark Pharms Revenue in Rufinamide Business (2016-2021) & (US$ Million)
    Table 70. Glenmark Pharms Recent Development
    Table 71. Mylan Company Details
    Table 72. Mylan Business Overview
    Table 73. Mylan Rufinamide Product
    Table 74. Mylan Revenue in Rufinamide Business (2016-2021) & (US$ Million)
    Table 75. Mylan Recent Development
    Table 76. West-ward Pharms Company Details
    Table 77. West-ward Pharms Business Overview
    Table 78. West-ward Pharms Rufinamide Product
    Table 79. West-ward Pharms Revenue in Rufinamide Business (2016-2021) & (US$ Million)
    Table 80. West-ward Pharms Recent Development
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Rufinamide Market Share by Type: 2020 VS 2027
    Figure 2. Tablets Features
    Figure 3. Oral suspension Features
    Figure 4. Global Rufinamide Market Share by Application: 2020 VS 2027
    Figure 5. Adults Case Studies
    Figure 6. Pediatric patients Case Studies
    Figure 7. Rufinamide Report Years Considered
    Figure 8. Global Rufinamide Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 9. Global Rufinamide Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Rufinamide Market Share by Regions: 2020 VS 2027
    Figure 11. Global Rufinamide Market Share by Regions (2022-2027)
    Figure 12. Global Rufinamide Market Share by Players in 2020
    Figure 13. Global Top Rufinamide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rufinamide as of 2020
    Figure 14. The Top 10 and 5 Players Market Share by Rufinamide Revenue in 2020
    Figure 15. Global Rufinamide Revenue Market Share by Type (2016-2021)
    Figure 16. Global Rufinamide Revenue Market Share by Type (2022-2027)
    Figure 17. North America Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 18. North America Rufinamide Market Share by Type (2016-2027)
    Figure 19. North America Rufinamide Market Share by Application (2016-2027)
    Figure 20. North America Rufinamide Market Share by Country (2016-2027)
    Figure 21. United States Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. Canada Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Europe Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Rufinamide Market Share by Type (2016-2027)
    Figure 25. Europe Rufinamide Market Share by Application (2016-2027)
    Figure 26. Europe Rufinamide Market Share by Country (2016-2027)
    Figure 27. Germany Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. France Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. U.K. Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Italy Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Russia Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Nordic Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Rufinamide Market Share by Type (2016-2027)
    Figure 35. Asia-Pacific Rufinamide Market Share by Application (2016-2027)
    Figure 36. Asia-Pacific Rufinamide Market Share by Region (2016-2027)
    Figure 37. China Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Japan Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. South Korea Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Southeast Asia Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. India Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Australia Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Latin America Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Rufinamide Market Share by Type (2016-2027)
    Figure 45. Latin America Rufinamide Market Share by Application (2016-2027)
    Figure 46. Latin America Rufinamide Market Share by Country (2016-2027)
    Figure 47. Mexico Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Brazil Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Rufinamide Market Share by Type (2016-2027)
    Figure 51. Middle East & Africa Rufinamide Market Share by Application (2016-2027)
    Figure 52. Middle East & Africa Rufinamide Market Share by Country (2016-2027)
    Figure 53. Turkey Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Saudi Arabia Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. UAE Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Eisai Revenue Growth Rate in Rufinamide Business (2016-2021)
    Figure 57. Glenmark Pharms Revenue Growth Rate in Rufinamide Business (2016-2021)
    Figure 58. Mylan Revenue Growth Rate in Rufinamide Business (2016-2021)
    Figure 59. West-ward Pharms Revenue Growth Rate in Rufinamide Business (2016-2021)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eisai
Glenmark Pharms
Mylan
West-ward Pharms
Frequently Asked Questions
Rufinamide report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rufinamide report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rufinamide report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Certolizumab pegol

Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn ... Read More

Degarelix

Degarelix (INN) or degarelix acetate (USAN), sold under the brand name Firmagon among others, is  ... Read More

Etravirine

Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment ... Read More

Lacosamide

Lacosamide (INN, formerly known as erlosamide, harkeroside, SPM 927, or ADD 234037), is a medicat ... Read More